Related Experiment Videos
Preclinical studies on L-671,152, a topically effective ocular hypotensive carbonic anhydrase inhibitor
M F Sugrue1, P Mallorga, H Schwam
1Merck Sharp and Dohme Research Labs, West Point, PA 19486.
British Journal of Pharmacology
|December 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Prediction of drug absorption using multivariate statistics.
Journal of medicinal chemistry·2000
Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry.
Proceedings of the National Academy of Sciences of the United States of America·2000
Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors.
Progress in retinal and eye research·1999
Small molecule antagonists of the bradykinin B1 receptor.
Immunopharmacology·1999
Effects of muscarinic cholinergic receptor antagonists on postnatal eye growth of rhesus monkeys.
Optometry and vision science : official publication of the American Academy of Optometry·1999
Identification and SAR for a selective, nonpeptidyl thrombin inhibitor.
Bioorganic & medicinal chemistry letters·1999
Metabolic remodelling in anthracycline cardiotoxicity: mechanisms and therapeutic insights.
British journal of pharmacology·2026
Photodynamic antimicrobial efficacy and mode of action of polypyridyl-based Ru(II) complexes against multidrug-resistant Klebsiella pneumoniae.
British journal of pharmacology·2026
Selective excitatory effects of γ-glutamyl-glycine, a glutathione metabolite, on GluN1 NMDA and mGlu5 receptors impacting synaptic plasticity.
British journal of pharmacology·2026
Generative Chemistry Platform for Small Molecules Targeting RNA: A Case Study for Chemical Optimization.
Computational and structural biotechnology journal·2026
Multi-state Structure Prediction of G Protein-Coupled Receptor Proteins via Prompting on AlphaFold.
Computational and structural biotechnology journal·2026
Bis-thiosemicarbazone derivative as starting agent for synthesis of anti-breast cancer agents and targeting PIM-1 kinase.
Future medicinal chemistry·2026
DFRL-Mol: a dual-stage framework of reinforcement learning for multi-scenario molecule optimization.
Briefings in bioinformatics·2026
AET5: A transcriptome-guided molecular generation framework with contrastive self-supervised learning.
PLoS computational biology·2026